BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37892105)

  • 1. Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy.
    Strange TA; Erasmus LT; Ahuja J; Agrawal R; Shroff GS; Truong MT; Strange CD
    Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of the post-radiation chest in lung cancer.
    Strange CD; Shroff GS; Truong MT; Nguyen QN; Vlahos I; Erasmus JJ
    Clin Radiol; 2022 Jan; 77(1):19-30. PubMed ID: 34090709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings.
    Benveniste MF; Welsh J; Viswanathan C; Shroff GS; Betancourt Cuellar SL; Carter BW; Marom EM
    Radiol Clin North Am; 2018 May; 56(3):471-483. PubMed ID: 29622079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.
    Diwanji TP; Mohindra P; Vyfhuis M; Snider JW; Kalavagunta C; Mossahebi S; Yu J; Feigenberg S; Badiyan SN
    Transl Lung Cancer Res; 2017 Apr; 6(2):131-147. PubMed ID: 28529896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study.
    Liu YE; Lin Q; Meng FJ; Chen XJ; Ren XC; Cao B; Wang N; Zong J; Peng Y; Ku YJ; Chen Y
    Radiat Oncol; 2013 Aug; 8(1):198. PubMed ID: 23937855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.
    Imano N; Kimura T; Kawahara D; Nishioka R; Fukumoto W; Kawano R; Kubo K; Katsuta T; Takeuchi Y; Nishibuchi I; Murakami Y; Horimasu Y; Masuda T; Fujitaka K; Hattori N; Nagata Y
    Jpn J Clin Oncol; 2021 Dec; 51(12):1729-1735. PubMed ID: 34625805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Radiation Treatment of Lung Cancer.
    Benveniste MF; Betancourt Cuellar SL; Gomez D; Shroff GS; Carter BW; Benveniste APA; Marom EM
    Semin Ultrasound CT MR; 2018 Jun; 39(3):297-307. PubMed ID: 29807640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
    Wu CT; Motegi A; Motegi K; Hotta K; Kohno R; Tachibana H; Kumagai M; Nakamura N; Hojo H; Niho S; Goto K; Akimoto T
    Jpn J Clin Oncol; 2016 Nov; 46(11):1008-1014. PubMed ID: 27511988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer.
    Badellino S; Muzio JD; Schivazappa G; Guarneri A; Ragona R; Bartoncini S; Trino E; Filippi AR; Fonio P; Ricardi U
    Br J Radiol; 2017 Oct; 90(1078):20170143. PubMed ID: 28749172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute and subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity-modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy and high-dose-rate brachytherapy.
    Morimoto M; Yoshioka Y; Konishi K; Isohashi F; Takahashi Y; Ogata T; Koizumi M; Teshima T; Bijl HP; van der Schaaf A; Langendijk JA; Ogawa K
    Tumori; 2014; 100(3):265-71. PubMed ID: 25076236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Non-coplanar Three-dimensional Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, and Volumetric Modulated Radiation Therapy for the Delivery of Stereotactic Ablative Radiation Therapy to Peripheral Lung Cancer.
    Fitzgerald R; Owen R; Hargrave C; Pryor D; Lehman M; Bernard A; Mai T; Seshadri V; Fielding A
    J Med Imaging Radiat Sci; 2017 Dec; 48(4):360-369. PubMed ID: 31047471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges.
    Ishikura S
    Gen Thorac Cardiovasc Surg; 2012 Mar; 60(3):127-31. PubMed ID: 22419179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Sagae S; Toita T; Matsuura M; Saito M; Matsuda T; Sato N; Shimizu A; Endo T; Fujii M; Gaffney DK; Small W
    Int J Gynecol Cancer; 2023 Aug; 33(8):1295-1303. PubMed ID: 37041022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the use of AAA and AcurosXB algorithms for three different stereotactic ablative body radiotherapy (SABR) techniques: Volumetric modulated arc therapy (VMAT), intensity modulated radiation therapy (IMRT) and 3D conformal radiotherapy (3D-CRT).
    Tajaldeen A; Ramachandran P; Alghamdi S; Geso M
    Rep Pract Oncol Radiother; 2019; 24(4):399-408. PubMed ID: 31333334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.
    Gomez DR; Tucker SL; Martel MK; Mohan R; Balter PA; Lopez Guerra JL; Liu H; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1010-6. PubMed ID: 22920974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
    Han C; Schultheiss TE; Wong JYC
    Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.